Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-052564
Filing Date
2021-08-19
Accepted
2021-08-19 17:05:50
Documents
1
Period of Report
2021-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10676
  Complete submission text file 0001209191-21-052564.txt   12107
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address
Litton Mark James (Reporting) CIK: 0001604834 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 211190970

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)